Monthly Prescribing Reference

Stiolto Respimat Launched for COPD

Stiolto Respimat received approval from the Food and Drug Administration (FDA) in May 2015. The Respimat inhaler actively delivers a slow-moving mist that aids the patient independent of inspiratory ...
News Medical

STIOLTO RESPIMAT Inhalation Spray now available for treatment of COPD across the U.S.

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that STIOLTO™ RESPIMAT ® (tiotropium bromide and olodaterol) Inhalation Spray is now available by prescription at pharmacies across the ...
Yahoo

FDA approves Boehringer Ingelheim’s Stiolto™* Respimat® as once-daily maintenance treatment for COPD

Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) approved once-daily Stiolto™ Respimat ® (tiotropium bromide and olodaterol) Inhalation Spray. It has been approved ...
Business Insider

FDA Approves Stiolto® Respimat® Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction

RIDGEFIELD, Conn., Oct. 11, 2018 /PRNewswire/ -- Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) approved new labeling for Stiolto Respimat (tiotropium bromide & ...
Medscape

FDA Approves Stiolto Respimat for COPD

The US Food and Drug Administration (FDA) last week approved a once-daily oral inhalation spray combining tiotropium and olodaterol (Stiolto Respimat, Boehringer Ingelheim) for chronic obstructive ...
Monthly Prescribing Reference

Stiolto Respimat Labeling Updated With COPD Exacerbation Data, Revised Indication

In addition to the new exacerbation data, the indication for Stiolto Respimat has been revised. The Food and Drug Administration (FDA) has approved updated labeling for Stiolto Respimat (tiotropium ...
Business Wire

Anthem, HealthCore and Boehringer Ingelheim Initiate World’s Largest Pragmatic Clinical Trial to Study People Living with COPD in a Real-World Setting

INDIANAPOLIS & RIDGEFIELD, Conn.--(BUSINESS WIRE)--The first patients have now enrolled in AIRWISE, the world’s largest ever pragmatic clinical trial in chronic obstructive pulmonary disease (COPD) to ...
Healio

Stiolto Respimat helps improve QOL in patients with COPD

Please provide your email address to receive an email when new articles are posted on . Stiolto Respimat helped improve quality of life and lung function in patients with COPD, according to study ...
FiercePharma

Just breathe: Boehringer Ingelheim's latest COPD campaign centers on 'inhaleability'

Taking a deep breath can be hard for COPD patients. The irony is, that's exactly what they often need to do to release their medicine from inhalers. That's why Boehringer Ingelheim’s latest ad ...
WFLA News Channel 8

Boehringer Ingelheim Welcomes New 2023 GOLD Report Positioning LAMA/LABA as the Preferred Treatment for the Majority of Patients with COPD

RIDGEFIELD, Conn. and NORWALK, Conn., Nov. 17, 2022 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals Inc. welcomes the updated 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) ...
Healio

FDA approves Stiolto Respimat for treatment of COPD

Please provide your email address to receive an email when new articles are posted on . The FDA approved Stiolto Respimat for the once-daily maintenance treatment in patients with COPD as well as ...